DNA MANAGEMENT

The annual accounts of DNA MANAGEMENT for financial year 2025 show a net loss of 55% of total assets and of 94% of the equity at the start of that year. The 2025 annual accounts show equity of €1,220 and a net result of -€20,507. Equity is shrinking by about 46% per year and would, assuming unchanged policy, indicatively turn negative around financial year 2026. Its solvency ranks better than 11% of 39,184 sector peers (NACE 70, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The computed 12-month bankruptcy probability is 0.5% (very low).